We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$75.6B
AUM Growth
+$332M
(+0.44%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
9.2%
Holding
2,306
New
139
Increased
928
Reduced
1,013
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$234M |
| 2 |
eBay
EBAY
|
+$223M |
| 3 |
Walt Disney
DIS
|
+$189M |
| 4 |
Humana
HUM
|
+$184M |
| 5 |
DXC Technology
DXC
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$236M |
| 2 |
Citizens Financial Group
CFG
|
+$157M |
| 3 |
Applied Materials
AMAT
|
+$156M |
| 4 |
Huntsman Corp
HUN
|
+$154M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.77% |
| 2 | Technology | 16.07% |
| 3 | Industrials | 14.94% |
| 4 | Consumer Discretionary | 12.29% |
| 5 | Healthcare | 11.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACH
2026
DELISTED
Alum Corp of China Ltd
ACH
| $314K | ﹤0.01% |
24,345
-2,021
| -8% | -$24.5K |
|
|
JCP
2027
DELISTED
J.C. Penney Company, Inc.
JCP
| $306K | ﹤0.01% |
65,741
+29,681
| +82% | +$152K |
|
|
DERM
2028
DELISTED
Dermira, Inc.
DERM
| $306K | ﹤0.01% |
10,485
+2,019
| +24% | +$61.4K |
|
2029
Glacier Bancorp
GBCI
$6.57B
| $305K | ﹤0.01% |
8,343
-8,575
| -51% | -$293K |
|
2030
Minerva Neurosciences
NERV
$191M
| $305K | ﹤0.01% |
4,303
| – | – |
|
2031
Halozyme
HALO
$9.81B
| $304K | ﹤0.01% |
23,748
+8,202
| +53% | +$110K |
|
2032
Ezcorp Inc
EZPW
$1.88B
| $303K | ﹤0.01% |
39,378
-10,873
| -22% | -$94.7K |
|
2033
Unisys
UIS
$217M
| $303K | ﹤0.01% |
23,658
-1,373
| -5% | -$16.7K |
|
|
ARII
2034
DELISTED
American Railcar Industries, Inc.
ARII
| $303K | ﹤0.01% |
7,906
-6,639
| -46% | -$256K |
|
|
NIHD
2035
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $303K | ﹤0.01% |
377,302
-52,606
| -12% | -$40.2K |
|
2036
Build-A-Bear
BBW
$425M
| $302K | ﹤0.01% |
28,857
-19,898
| -41% | -$203K |
|
2037
BioCryst Pharmaceuticals
BCRX
$2.27B
| $302K | ﹤0.01% |
54,322
+12,571
| +30% | +$76.6K |
|
2038
PC Connection
CNXN
$2.17B
| $302K | ﹤0.01% |
11,148
+1,622
| +17% | +$44.7K |
|
2039
Modine Manufacturing
MOD
$10.5B
| $300K | ﹤0.01% |
18,154
-54,318
| -75% | -$740K |
|
2040
Carriage Services
CSV
$638M
| $297K | ﹤0.01% |
11,034
| – | – |
|
2041
Donaldson
DCI
$11.2B
| $297K | ﹤0.01% |
6,513
+793
| +14% | +$36.5K |
|
|
NETI
2042
DELISTED
Eneti Inc.
NETI
| $297K | ﹤0.01% |
4,495
+970
| +28% | +$63.6K |
|
|
HZN
2043
DELISTED
Horizon Global Corporation
HZN
| $297K | ﹤0.01% |
20,711
-49,196
| -70% | -$696K |
|
|
GPOR
2044
DELISTED
Gulfport Energy Corp.
GPOR
| $295K | ﹤0.01% |
19,991
| – | – |
|
2045
Aclaris Therapeutics
ACRS
$788M
| $294K | ﹤0.01% |
+10,825
| New | +$294K |
|
|
RAVN
2046
DELISTED
Raven Industries Inc
RAVN
| $293K | ﹤0.01% |
8,805
| – | – |
|
|
PCMI
2047
DELISTED
PCM, Inc
PCMI
| $292K | ﹤0.01% |
+15,549
| New | +$340K |
|
|
AIMT
2048
DELISTED
Aimmune Therapeutics
AIMT
| $290K | ﹤0.01% |
+14,096
| New | +$269K |
|
2049
Daktronics
DAKT
$1.04B
| $289K | ﹤0.01% |
30,031
+13,742
| +84% | +$130K |
|
2050
Pulse Biosciences
PLSE
$2.64B
| $289K | ﹤0.01% |
+8,357
| New | +$230K |
|
Similar funds
AQR Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, AQR Capital Management held 2,306 positions worth $75.6B, up 0.44% from $75.2B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
AQR Capital Management's Q2 2017 filing shows 139 new, 928 increased, 1,013 reduced and 118 closed positions. Its largest new stake was DXC Technology: 2,594,054 shares worth $172M. The largest sale was Wells Fargo, an estimated $236M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
- AQR Capital Management's largest Q2 2017 buy was DXC Technology: 2,594,054 shares worth $172M.
- AQR Capital Management added most to Gilead Sciences in Q2 2017, an estimated $234M increase.
- AQR Capital Management's biggest Q2 2017 reduction was Wells Fargo, cutting an estimated $236M.
- AQR Capital Management fully exited Computer Sciences in Q2 2017, selling an estimated $77.8M.
- AQR Capital Management's ten largest holdings make up 9.2% of its $75.6B portfolio in Q2 2017.
- AQR Capital Management opened 139 new positions and closed 118 in Q2 2017.
- AQR Capital Management's portfolio value rose 0.44% quarter-over-quarter to $75.6B.
Based on AQR Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.